Apollo Healthtech to List by 2027: Promoters to Remain in Charge
PorAinvest
martes, 12 de agosto de 2025, 8:58 pm ET1 min de lectura
APO--
In addition to its strong financial performance, Apollo Healthtech is also investing heavily in artificial intelligence (AI) capabilities. The company plans to double its investment in AI over the next two to three years. This investment includes developing AI tools to read X-rays, scan reports, and even predict the risk of liver fibrosis. Apollo Healthtech has partnered with Microsoft to develop these AI-based tools, which are currently in the early stages of testing [2].
The company's focus on AI is part of a broader strategy to improve patient diagnosis and decisions related to medical procedures. This investment aligns with the growing trend among large private hospital chains in India to adopt AI technologies to enhance their services. Apollo Healthtech's overall bed capacity is expected to increase by 4,370 beds over the next 3-4 years through acquisitions, new hospitals, and expansions of existing facilities.
Apollo Healthtech's Q1 total revenue rose by 15% to ₹58.42 billion, beating estimates of ₹57.44 billion. The company expects double-digit revenue growth for the current financial year. Despite a dip in overall occupancy rates, in-patient volume grew by 3% and average revenue per in-patient increased by 9% [1].
References:
[1] https://www.reuters.com/world/india/indias-apollo-hospitals-double-ai-investments-beats-profit-estimate-2025-08-12/
[2] https://www.reuters.com/world/india/apollo-hospitals-q1-profit-rises-strong-demand-2025-08-12/
MSFT--
Apollo Healthtech, the demerged business of Apollo Hospitals, is targeting a listing by January-March 2027. The company's CFO, Krishnan Akhileswaran, said there are no plans for a family reorganization, and the promoters will remain directors in the new company. Apollo Hospitals posted a 42% on-year rise in Q1 consolidated net profit to ₹433 crore, driven by double-digit growth in all business segments.
Apollo Healthtech, the demerged business of Apollo Hospitals, is targeting a listing by January-March 2027. The company's CFO, Krishnan Akhileswaran, confirmed that there are no plans for a family reorganization, and the promoters will remain directors in the new company. Apollo Hospitals posted a 42% on-year rise in Q1 consolidated net profit to ₹433 crore, driven by double-digit growth in all business segments [1].In addition to its strong financial performance, Apollo Healthtech is also investing heavily in artificial intelligence (AI) capabilities. The company plans to double its investment in AI over the next two to three years. This investment includes developing AI tools to read X-rays, scan reports, and even predict the risk of liver fibrosis. Apollo Healthtech has partnered with Microsoft to develop these AI-based tools, which are currently in the early stages of testing [2].
The company's focus on AI is part of a broader strategy to improve patient diagnosis and decisions related to medical procedures. This investment aligns with the growing trend among large private hospital chains in India to adopt AI technologies to enhance their services. Apollo Healthtech's overall bed capacity is expected to increase by 4,370 beds over the next 3-4 years through acquisitions, new hospitals, and expansions of existing facilities.
Apollo Healthtech's Q1 total revenue rose by 15% to ₹58.42 billion, beating estimates of ₹57.44 billion. The company expects double-digit revenue growth for the current financial year. Despite a dip in overall occupancy rates, in-patient volume grew by 3% and average revenue per in-patient increased by 9% [1].
References:
[1] https://www.reuters.com/world/india/indias-apollo-hospitals-double-ai-investments-beats-profit-estimate-2025-08-12/
[2] https://www.reuters.com/world/india/apollo-hospitals-q1-profit-rises-strong-demand-2025-08-12/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios